PubMedCentralPubMedCrossRef 16. Cotter SE, Surana NK, 3rd St Geme JW: Trimeric autotransporters: a distinct subfamily of autotransporter VX-689 manufacturer proteins. Trends Microbiol
2005,13(5):199–205.PubMedCrossRef 17. Henderson IR, Navarro-Garcia F, Nataro JP: The great escape: structure and function of the autotransporter proteins. Trends Microbiol 1998,6(9):370–378.PubMedCrossRef 18. Stathopoulos C, Hendrixson DR, Thanassi DG, Hultgren SJ, 3rd St Geme JW, 3rd Curtiss R: Secretion of virulence determinants by the general secretory pathway in gram-negative pathogens: an evolving story. Microbes Infect 2000,2(9):1061–1072.PubMedCrossRef 19. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala’Aldeen D: Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004,68(4):692–744.PubMedCentralPubMedCrossRef 20. Linke D, Riess T, Autenrieth IB, Lupas A, Kempf VA: Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol 2006,14(6):264–270.PubMedCrossRef 21. Hoiczyk E, Roggenkamp A, Reichenbecher M, Lupas A, AMN-107 supplier Heesemann J: Structure and AZD1152 manufacturer sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. Embo J 2000,19(22):5989–5999.PubMedCentralPubMedCrossRef 22. Ciabattini A, Giomarelli B, Parigi R, Chiavolini D, Pettini E, Arico B, Giuliani
MM, Santini L, Medaglini D, Pozzi G: Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. Vaccine 2008,26(33):4244–4250.PubMedCrossRef 23. Bowe F, Lavelle EC, McNeela EA, Hale C, Clare S, Arico B, Giuliani MM, Rae A, Huett A, Rappuoli R, Dougan G, Mills KH: Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants
of Escherichia coli heat-labile enterotoxin. Infect Immun 2004,72(7):4052–4060.PubMedCentralPubMedCrossRef 24. Liu DF, Mason KW, Mastri M, Pazirandeh M, Cutter D, Fink DL, 3rd St Geme JW, Zhu D, Green BA: The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus Farnesyltransferase influenzae is a potential vaccine candidate. Infect Immun 2004,72(12):6961–6968.PubMedCentralPubMedCrossRef 25. Cutter D, Mason KW, Howell AP, Fink DL, Green BA, 3rd St Geme JW: Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J Infect Dis 2002,186(8):1115–1121.PubMedCrossRef 26. Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HL: Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect Immun 2009,77(2):632–641.PubMedCentralPubMedCrossRef 27. Waag DM, Deshazer D: Glanders: New Insights into an old Disease. In Biological Weapons Defense: Infectious Diseases and Counterbioterrorism.